Bosnalijek's Lysobact wins prestigious award

Bosnalijek's medicine "Lysobact" won first place in the category of "sore throat medicines" with the highest sales in Russia, and the awards ceremony "Consumer Health Choice Awards 2017" was held on September 19 in Moscow, reports Patria News Agency.

More than 500 representatives of leading pharmaceutical companies attended the ceremony.

"Lysobact" is a unique product that contains the natural antiseptic lysozyme without substances foreign to the body. Given the spectrum of action of the antiseptic lysozyme, "Lysobact" eliminates the causes of sore throat – viruses, bacteria, and fungi. As Bosnalijek's highest quality product with modern quality control, "Lysobact" has set the standard for sore throat medicines containing lysozyme.

Valentina Buchneva, director of Bosnalijek's Eurasian department, said they are very happy to have won this prestigious award.

Buchneva said that "Lysobact", first registered in the USSR in 1982, became popular due to its unique advantages: natural safety and a spectrum of antiseptic action. "Lysobact" is the only medicine containing lysozyme on the Russian market for sore throat medicines that does not contain "chemical" antiseptics. This fact makes "Lysobact" an optimal choice not only for adults but also for sensitive consumer groups, such as children, pregnant women, and nursing mothers.

Under the auspices of QuintilesIMS, an American multinational company providing services to mixed industries of health information technology and clinical research, the "Consumer Health Choice" award is a direct testament to success in the Russian pharmaceutical market.

By evaluating sales results over 12 months from a wide range of retail chains, QuintilesIMS provides an objective picture of the marketing strategy and communication effectiveness, and the overall business of the pharmaceutical company.

In addition to this award, which is another achievement for Bosnalijek in 2017, it should be noted that in March they received a GMP certificate issued by the Ministry of Industry and Trade of the Russian Federation, making them one of the first companies operating in Russia with a European production location to pass the Russian GMP inspection.